HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyriakoula Marinou Selected Research

Galactitol

3/2005Suckling rat brain regional distribution of Na+,K+-atpase activity in the in vitro galactosaemia: the effect of L-cysteine and glutathione.
3/2005Mg2+-ATPase activity in suckling rat brain regions in galactosaemia in vitro. L-Cysteine and glutathione effects.
11/2002The in vitro effects of galactose and its derivatives on rat brain Mg2+-ATPase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyriakoula Marinou Research Topics

Disease

13Atherosclerosis
03/2012 - 05/2006
6Galactosemias (Galactosemia)
09/2005 - 09/2002
5Inflammation (Inflammations)
03/2012 - 03/2010
5Coronary Artery Disease (Coronary Atherosclerosis)
10/2011 - 01/2005
4Type 2 Diabetes Mellitus (MODY)
05/2011 - 02/2007
4Hyperemia
06/2008 - 06/2003
3Insulin Resistance
10/2015 - 01/2010
3Homocysteinemia
08/2011 - 06/2008
3Body Weight (Weight, Body)
05/2010 - 06/2008
3Myocardial Infarction
05/2006 - 09/2005
2Heart Failure
05/2009 - 05/2007
2Thrombosis (Thrombus)
04/2009 - 06/2003
1Abdominal Obesity
10/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2012
1Atrial Fibrillation
01/2012
1Rheumatoid Arthritis
07/2011
1Diabetes Mellitus
05/2011
1Muscular Diseases (Myopathy)
09/2010
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
09/2010
1Muscle Cramp (Cramp)
09/2010
1Obesity
01/2010
1Acute-Phase Reaction
05/2009
1ST Elevation Myocardial Infarction
04/2009
1Stroke (Strokes)
01/2009
1Aortic Coarctation
02/2008
1Hypertension (High Blood Pressure)
02/2008
1Edema (Dropsy)
03/2005

Drug/Important Bio-Agent (IBA)

5Atorvastatin (Lipitor)FDA Link
07/2011 - 02/2007
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2011 - 04/2009
5CytokinesIBA
05/2009 - 02/2006
4EnzymesIBA
10/2011 - 09/2002
4VitaminsIBA
08/2011 - 06/2003
3dimethylarginineIBA
08/2011 - 02/2007
3Methionine (L-Methionine)FDA Link
08/2011 - 06/2008
3AntioxidantsIBA
08/2011 - 06/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2011 - 11/2006
3Glucose (Dextrose)FDA LinkGeneric
05/2011 - 11/2002
3von Willebrand FactorIBA
04/2009 - 09/2005
3HomocysteineIBA
01/2009 - 01/2005
3Ca(2+) Mg(2+)-ATPaseIBA
03/2005 - 11/2002
3Galactose (Galactopyranose)FDA LinkGeneric
03/2005 - 11/2002
3GalactitolIBA
03/2005 - 11/2002
2sapropterin (tetrahydrobiopterin)FDA Link
10/2011 - 07/2011
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
07/2011 - 09/2005
2Interleukin-6 (Interleukin 6)IBA
07/2011 - 04/2009
2Metformin (Glucophage)FDA LinkGeneric
05/2011 - 09/2010
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
05/2010 - 02/2007
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
04/2009 - 06/2008
2oxidized low density lipoproteinIBA
06/2008 - 09/2005
2InterleukinsIBA
02/2006 - 09/2005
2Nitroglycerin (Dynamite)FDA LinkGeneric
02/2006 - 06/2003
2P-2 (P 2)IBA
09/2005 - 03/2005
21-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
09/2005 - 03/2005
2Adenosine Triphosphatases (ATPase)IBA
03/2005 - 05/2004
2galactose-1-phosphateIBA
03/2005 - 11/2002
1Fatty Acids (Saturated Fatty Acids)IBA
10/2015
1very low density lipoprotein triglycerideIBA
10/2015
1VLDL LipoproteinsIBA
10/2015
1Triglycerides (Triacylglycerol)IBA
10/2015
1Insulin-Like Growth Factor Binding Protein 1IBA
01/2014
1Hormones (Hormone)IBA
03/2012
1AdiponectinIBA
03/2012
1Biomarkers (Surrogate Marker)IBA
03/2012
1NADP (NADPH)IBA
01/2012
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2012
1BiopterinsIBA
10/2011
1C-Reactive ProteinIBA
10/2011
1GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
10/2011
1VaccinesIBA
10/2011
1Nitric Oxide Synthase (NO Synthase)IBA
07/2011
1Blood Glucose (Blood Sugar)IBA
09/2010
1Vitamin EFDA LinkGeneric
05/2010
1Endothelin-1 (Endothelin 1)IBA
05/2010
1Type 2 Angiotensin ReceptorIBA
03/2010
1Angiotensin IIIBA
03/2010
1AdipokinesIBA
01/2010
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009
1Plasminogen Activators (Plasminogen Activator)IBA
04/2009
1Tissue Plasminogen Activator (Alteplase)FDA Link
04/2009
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2009
1Ramipril (Altace)FDA LinkGeneric
02/2008
1Insulin (Novolin)FDA Link
06/2007
1DobutamineFDA LinkGeneric
05/2007
1N- (4- (4- methyl- 6- oxo- 1,4,5,6- tetrahydropyridazin- 3- yl)phenyl)acetamide (OR 1896)IBA
05/2007
1Simendan (Levosimendan)IBA
05/2007
1CD40 Ligand (CD40L)IBA
05/2006
1Integrin alpha2IBA
05/2006
1Lipoproteins (Lipoprotein)IBA
05/2006
1LipidsIBA
05/2006
1Phosphates (Orthophosphate)IBA
03/2005
1Free RadicalsIBA
05/2004
1glucose-1-phosphateIBA
11/2002

Therapy/Procedure

1Length of Stay
01/2012
1Therapeutics
05/2011
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2010
1Injections
06/2009
1Sublingual Administration
02/2006